FGL2 can lead to phosphorylation of ERK and p38 through thrombin production and subsequent activation of PAR1 and PAR3, or JNK through activation of PAR2, and these late cellular activities promote survival and proliferation, tumor growth and angiogenesis in hepatocellular carcinoma. Here, FGL2 is linked to neoplasm.